Fact CheckerSign in

NCT06718569Recruiting

Pain in Inflammatory Joint Diseases

Advancing the Understanding of Pain Mechanisms in Inflammatory Arthritis Towards Precision Pain Management

Source: ClinicalTrials.gov · Last updated 13 Apr 2026

Brief summary (registry, in English)

Our primary objective is to better understand the etiology and consequences of chronic paint by using an explorative approach to identify phenotypes and endotypes of patients with inflammatory joint diseases, with a special focus on central sensitization and cognitive functioning as a key element in chronic pain. We will also examine the risk factors and clinical impact of these factors on pain, disease activity and treatment effects in a longitudinal study of patients with inflammatory joint disesases.

Status (registry)
Recruiting
Study type
Observational
Enrollment
350 (estimated)
First submitted
2 Dec 2024
Start date
11 Nov 2025
Primary completion date
Nov 2027
Lead sponsor
Diakonhjemmet Hospital
NCT number
NCT06718569

What you commit to

  • Study type: Observational
  • Planned participants: 350
  • From 11 Nov 2025 to the primary completion date, Nov 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • None

Who the study is looking for

  • All patients who initiate or switch biological or targeted synthetic DMARDs

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Diakonhjemmet Hospital
Coordinator of this site? Confirm its status
OsloNorwayRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.